Background The National Eczema Association has received increasing numbers of patient
inquiries regarding “steroid addiction syndrome,” coinciding with the growing presence of …

Importance Topical corticosteroid (TCS) phobia refers to the negative feelings and beliefs
related to TCSs experienced by patients and patients' caregivers. This phenomenon may be …

The evidence‐and consensus‐based guideline on atopic eczema was developed in
accordance with the EuroGuiDerm Guideline and Consensus Statement Development …

Background Ruxolitinib (RUX) cream demonstrated potent anti-inflammatory and antipruritic
efficacy in a phase 2 study in adults with atopic dermatitis (AD). Objective To evaluate 8 …

This guideline was developed as a joint interdisciplinary European project, including
physicians from all relevant disciplines as well as patients. It is a consensus‐based …

BACKGROUND AND OBJECTIVES: Atopic dermatitis (AD) primarily affects infants and
young children. Although topical corticosteroids (TCSs) are often prescribed …

Atopic dermatitis (AD) is the long-lasting chronic inflammatory skin condition associated with
cutaneous hyper-reactivity and triggered by environmental factors. The attributes of AD …

Objective An umbrella review summarising all safety data from systematic reviews of topical
corticosteroids (TCS) in adults and children with atopic eczema. Methods Embase …

Introduction: Until now, the main focus of medication adherence research has been oral
drugs. Fewer studies have examined adherence to topical drugs. The issue of patient …

Background Atopic dermatitis (AD) is a chronic relapsing skin disease prevalent in 1% to 3%
of adults in Western industrialized countries. Objective We sought to investigate the …